Memorializes President and Congress to expand certain benefits to grandchildren of veterans impacted by Agent Orange.
The resolution calls for a meaningful update to the existing legislation to include these grandchildren in the benefits program. It argues that the children of these veterans who suffer from Spina Bifida are eligible for a range of benefits, including monetary allowances, vocational training, and healthcare. As such, including grandchildren in these benefits would alleviate considerable financial burdens and provide essential services for managing this debilitating condition. ACR99 emphasizes that health issues related to Spina Bifida lead to lifelong care and significant medical costs, hence advocating for equal support for both generations affected.
Assembly Concurrent Resolution No. 99 (ACR99) memorializes the President and Congress of the United States to extend benefits to the grandchildren of veterans who are affected by Spina Bifida due to exposure to Agent Orange. This resolution highlights that grandsons and granddaughters of veterans who served in the Korean and Vietnam Wars face significant health challenges related to their grandparents' service, similar to those experienced by veterans' children. Current federal law only provides support to the children of such veterans under the Agent Orange Benefits Act of 1996, leaving their grandchildren without critical assistance.
Notably, the resolution points to emerging evidence that suggests grandchildren of veterans exposed to Agent Orange also have increased rates of Spina Bifida. Despite the awareness of this health issue, the exclusion of these grandchildren from eligibility for benefits under the existing act is viewed as a significant oversight. Advocacy for extending these benefits is likely to face political challenges, particularly around funding and legislative jurisdiction. However, proponents argue that the moral obligation of the nation to support all service members’ descendants is paramount, given the sacrifices made by veterans.